【レポートの概要(一部)】
Table of Contents
Table of Contents 2
List of Tables 5
List of Figures 6
Introduction 7
Global Markets Direct Report Coverage 7
Thalassemia Overview 8
Therapeutics Development 9
Pipeline Products for Thalassemia – Overview 9
Pipeline Products for Thalassemia – Comparative Analysis 10
Thalassemia – Therapeutics under Development by Companies 11
Thalassemia – Therapeutics under Investigation by Universities/Institutes 12
Thalassemia – Pipeline Products Glance 13
Late Stage Products 13
Clinical Stage Products 14
Early Stage Products 15
Thalassemia – Products under Development by Companies 16
Thalassemia – Products under Investigation by Universities/Institutes 18
Thalassemia – Companies Involved in Therapeutics Development 19
Acceleron Pharma, Inc. 19
Acetylon Pharmaceuticals, Inc. 20
Acino Pharma AG 21
Alnylam Pharmaceuticals, Inc. 22
Bluebird bio, Inc. 23
Emmaus Medical, Inc. 24
Errant Gene Therapeutics, LLC 25
Gamida Cell Ltd. 26
Incyte Corporation 27
IRBM Science Park SpA 28
Isis Pharmaceuticals, Inc. 29
Johnson & Johnson 30
Protagonist Therapeutics Inc. 31
Sangamo BioSciences, Inc. 32
Thalassemia – Therapeutics Assessment 33
Assessment by Monotherapy Products 33
Assessment by Target 34
Assessment by Mechanism of Action 36
Assessment by Route of Administration 38
Assessment by Molecule Type 40
Drug Profiles 42
ACY-957 – Drug Profile 42
Product Description 42
Mechanism of Action 42
R&D Progress 42
ALN-TMP – Drug Profile 43
Product Description 43
Mechanism of Action 43
R&D Progress 43
Antisense Oligonucleotides to Inhibit BCL11A and KLF1 for Hematological Disorders – Drug Profile 44
Product Description 44
Mechanism of Action 44
R&D Progress 44
BB-305 – Drug Profile 45
Product Description 45
Mechanism of Action 45
R&D Progress 45
BtX-13 – Drug Profile 47
Product Description 47
Mechanism of Action 47
R&D Progress 47
CNTO-530 – Drug Profile 48
Product Description 48
Mechanism of Action 48
R&D Progress 48
Gene Therapy for Sickle Cell Disease and Beta Thalassemia – Drug Profile 49
Product Description 49
Mechanism of Action 49
R&D Progress 49
Gene Therapy for Sickle Cell Disease and Thalassemia – Drug Profile 50
Product Description 50
Mechanism of Action 50
R&D Progress 50
glutamine – Drug Profile 51
Product Description 51
Mechanism of Action 51
R&D Progress 51
luspatercept – Drug Profile 53
Product Description 53
Mechanism of Action 53
R&D Progress 53
NiCord – Drug Profile 54
Product Description 54
Mechanism of Action 54
R&D Progress 54
PB-04 – Drug Profile 55
Product Description 55
Mechanism of Action 55
R&D Progress 55
Peptide Agonists of Hepcidin for Beta-Thalassemia and Juvenile Hemochromatosis – Drug Profile 56
Product Description 56
Mechanism of Action 56
R&D Progress 56
Project x-1450 – Drug Profile 57
Product Description 57
Mechanism of Action 57
R&D Progress 57
ruxolitinib phosphate – Drug Profile 58
Product Description 58
Mechanism of Action 58
R&D Progress 58
Small Molecule to Inhibit Histone Deacetylase for Beta-Thalassemia – Drug Profile 63
Product Description 63
Mechanism of Action 63
R&D Progress 63
sotatercept – Drug Profile 64
Product Description 64
Mechanism of Action 64
R&D Progress 64
Stem Cell Therapy for Beta Thalassemia – Drug Profile 66
Product Description 66
Mechanism of Action 66
R&D Progress 66
Synthetic Peptides Hematological and Genetic Disorders – Drug Profile 67
Product Description 67
Mechanism of Action 67
R&D Progress 67
Thalagen – Drug Profile 69
Product Description 69
Mechanism of Action 69
R&D Progress 69
Thalassemia – Recent Pipeline Updates 70
Thalassemia – Dormant Projects 90
Thalassemia – Product Development Milestones 91
Featured News & Press Releases 91
Feb 04, 2015: Sangamo BioSciences Announces FDA Acceptance of IND to Initiate Clinical Trial of its Novel ZFP Therapeutic for Beta-Thalassemia 91
Dec 08, 2014: Acetylon Pharmaceuticals Presents Positive Preclinical Data on Selective HDAC1/2 Inhibition for the Treatment of Sickle Cell Disease/ß-thalassemia 92
Dec 07, 2014: New Data from Luspatercept Phase 2 Clinical Trial in Beta-Thalassemia Presented at the 56th American Society of Hematology (ASH) Annual Meeting and Exposition 92
Nov 06, 2014: Acceleron Announces New Clinical Data Presentations on luspatercept at the 2014 American Society of Hematology Annual Meeting 94
Nov 06, 2014: Celgene To Present Phase II trial Results Update On Luspatercept at American Society of Hematology Annual Meeting 95
Nov 06, 2014: Acceleron Announces New Clinical Data Presentations on sotatercept at the 2014 American Society of Hematology Annual Meeting 95
Oct 01, 2014: Acceleron to Host Educational Webcast on Luspatercept 96
Oct 01, 2014: Acceleron to Host Educational Webcast on Beta-thalassemia 96
Jun 14, 2014: Celgene and Acceleron announces interim data from ACE-536 at the 19th European Hematology Association annual congress 96
Jun 14, 2014: Studies Presented at 19th European Hematology Association Annual Congress Evaluate Activin Receptor Ligand Trap Programs in Beta-Thalassemia 97
Appendix 99
Methodology 99
Coverage 99
Secondary Research 99
Primary Research 99
Expert Panel Validation 99
Contact Us 99
Disclaimer 100
【レポート販売概要】
■ タイトル:サラセミア(Thalassemia):治療薬開発パイプライン動向(2015年上半期版)■ 英文:Thalassemia - Pipeline Review, H1 2015
■ 発行日:2015年2月24日
■ 調査会社:Global Markets Direct
■ 商品コード:GMDHC6277IDB
■ 調査対象地域:グローバル
- コードレス造園機器の世界市場2019-2023About this market The continuously increasing product awareness through numerous marketing campaigns will foster the cordless garden equipment market growth during the forecast period. Campaigns against noise-generating garden equipment and growing calls for quieter alternatives will augment the market growth. Several programs are also encouraging the use of clean battery-powered lawns and garden …
- ICT投資の優先順位:メディア産業部門 – 企業のICT投資計画Why was the report written? In order to provide deeper insights into media companies’ ICT investment priorities and strategic objectives. What is the current market landscape and what is changing? Kable’s survey finds that a significant proportion of media companies have already invested in enterprise applications and these solutions are expected to receive higher investments in the next two years …
- トランスレーショナル再生医療の世界市場:幹細胞治療、ティッシュ・エンジニアリング治療、遺伝子治療Translational Regenerative Medicine - new study showing you trends, R&D progress, and predicted revenues Where is the market for regenerative medicine heading? What are the commercial prospects for this market and related technologies? Visiongain’s brand new report shows you potential revenues and other trends to 2025, discussing data, opportunities and prospects. Visiongain’s report lets you asse …
- 2014年戦略提言:イタリアの内分泌機能検査市場This new 269-page report from Venture Planning Group provides a comprehensive analysis in the Italian endocrine function market, including emerging tests, technologies, instrumentation, sales forecasts by country, market shares and strategic profiles of leading suppliers. The report provides test volume and sales forecasts by country and market segment for the following assays: Cortisol, Est …
- 機能性食品の世界市場分析:製品別(カロテノイド、食物繊維、脂肪酸、鉱物、プレバイオティクス・プロビオティック、ビタミン)、用途別、エンドユーザー別(スポーツ栄養、体重管理、免疫、消化器の健康)、セグメント予測、2014 – 2024The global functional foods market is expected to reach USD 255.10 billion by 2024, according to a new report by Grand View Research, Inc. Growing geriatric population, healthcare costs, consumers ‘consciousness towards their well-being, and changing lifestyle is expected to drive the functional foods market growth over the forecast period. These foods have the ability to combat various diseases p …
- LED製造装置の世界市場2015-2019About LED Production Equipment The fact that excessive use of energy for lighting is the main contributor to global warming has led to the adoption of energy-efficient technologies, such as LED lighting, by countries worldwide. LED production equipment is required to facilitate mass production of LEDs while maintaining quality. Thus, LED production equipment has a great significance in the LED sup …
- 世界のデジタル油田市場:分散制御システム、SCADA、スマートウェル、安全システム、ITサービスなどThe report has taken into consideration two scenarios and forecasted the market based on the assumptions made under each scenario. Scenario 1 is based on the current market environment which is characterized by participation from regions that have implemented the DOF solutions on a commercial basis. Scenario 2 presents a more optimistic projection for the market as it also takes into consideration …
- ハラール成分の世界市場展望2017-2026According to Stratistics MRC, the Global Halal Ingredients market is accounted for $40.17 billion in 2017 and is expected to reach $77.47 billion by 2026 growing at a CAGR of 7.6% during the forecast period. Healthy snacking and increasing awareness about functional food & beverage products are some of the factors boosting the growth of the market. However, the lack of consistency for Halal Standa …
- ETS6103 (大うつ病性障害):医薬品市場予測及び分析(~2023)ETS6103 (Major Depressive Disorder) - Forecast and Market Analysis to 2023 Summary Major depressive disorder (MDD) is one of the most common psychiatric diseases worldwide. The MDD market is a crowded and competitive market, with more than 30 marketed products available for the treatment of patients with MDD. The depression market is about to enter a dynamic phase with imminent patent expiries for …
- Approach Resources Inc.:石油・ガスの開発・生産動向及びコスト分析– Q4, 2012Approach Resources Inc. Oil & Gas Exploration and Production Operations and Cost Analysis – Q4, 2012 Summary Approach Resources Inc. Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential so …
- 加工スナックの世界市場:押出スナック、トルティーヤ・チップス、ポーク・スクラッチングAbout Processed Snacks Processed snacks are products that are less perishable and more portable than prepared foods. Though there are many variants in terms of the ingredients used, the processed snacks market can be divided into three categories: extruded snacks, tortilla chips/corn chips, and pork scratchings. Processed snacks are eaten in between meals. Their consumption has increased as breakf …
- 行動リハビリの世界市場の規模および予測:用途別(不安、気分障害、物質乱用、人格、注意欠陥障害)、医療現場別(入院患者、家庭内、外来患者)、動向の分析 2014-2025The global behavioral rehabilitation market is expected to reach USD 313.9 billion by 2025, according to a new report by Grand View Research, Inc. Behavioral rehabilitation market is anticipated to experience growth during the forecast period due to presence of favorable government initiatives, rising number of service providers, and growing awareness among patients. Furthermore, increasing incide …
- シミュレーション及び分析ソフトウェアの世界市場2017-2021About Simulation and Analysis Software Simulation and analysis software is one of the major segments of product life cycle management (PLM) software, and it has a 14% share in the global PLM software market. PLM customers need simulation and analysis tools to achieve long-term benefits of PLM software. Increasing adoption of PLM software enhances the demand for simulation and analysis software. Te …
- 世界におけるバイオメトリック(生体認証)システム市場2013-2023(主要プログラム)Synopsis This report provides information on major programs planned in the global Biometric System market. It provides details on top programs in each segment expected to be executed during the forecast period. Summary This report discusses the various programmes conducted by key players in the market, by dividing them into the main types of Biometric System. The report offers detailed information …
- 歯科用イメージング技術・装置の世界市場:X線、コーンビームCT(CBCT)、口腔内カメラ、光学式イメージングThe global dental imaging market is expected to reach $2,686.5 million by 2019 from $1,691.1 million in 2014, growing at a CAGR of 9.7% from 2014 to 2019. The global dental imaging market is categorized on the basis of technology, method, application, end user, and geography. The dental CBCT segment is expected to register the highest growth rate in the dental imaging market, by technology, during …